Critical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion

Критическая роль комплекса cAMP-GEFII–Rim2 в усилении секреции инсулина инкретинами
Yasushige Kashima, Takashi Miki, Tadao Shibasaki, Nobuaki Ozaki, Masaru Miyazaki, Hideki Yano, Susumu Seino
2001-12-01

PKA-independent exocytosisRim2cAMP-GEFII (Epac2)incretin-potentiated insulin secretionpancreatic beta-cells
Incretins such as glucagon-like peptide-1 and gastric inhibitory polypeptide/glucose-dependent insulinotropic peptide are known to potentiate insulin secretion mainly through a cAMP/protein kinase A (PKA) signaling pathway in pancreatic beta-cells, but the mechanism is not clear. We recently found that the cAMP-binding protein cAMP-GEFII (or Epac 2), interacting with Rim2, a target of the small G protein Rab3, mediates cAMP-dependent, PKA-independent exocytosis in a reconstituted system. In the present study, we investigated the role of the cAMP-GEFII--Rim2 pathway in incretin-potentiated insulin secretion in native pancreatic beta-cells. Treatment of pancreatic islets with antisense oligodeoxynucleotides (ODNs) against cAMP-GEFII alone or with the PKA inhibitor H-89 alone inhibited incretin-potentiated insulin secretion approximately 50%, while a combination of antisense ODNs and H-89 inhibited the secretion approximately 80-90%. The effect of cAMP-GEFII on insulin secretion is mediated by Rim2 and depends on intracellular calcium as well as on cAMP. Treatment of the islets with antisense ODNs attenuated both the first and second phases of insulin secretion potentiated by the cAMP analog 8-bromo-cAMP. These results indicate that the PKA-independent mechanism involving the cAMP-GEFII--Rim2 pathway is critical in the potentiation of insulin secretion by incretins.
1
Inhibiting cAMP-GEFII or PKA separately reduced incretin-potentiated insulin secretion by approximately 50%, whereas combined inhibition reduced secretion by approximately 80–90%.
2
Suppressing cAMP-GEFII attenuated both first- and second-phase insulin secretion potentiated by the cAMP analog 8-bromo-cAMP.
3
The cAMP-GEFII (Epac2)–Rim2 pathway mediates a PKA-independent component of incretin-potentiated insulin secretion in pancreatic beta-cells.
4
The findings establish the cAMP-GEFII–Rim2 complex as a critical mediator of incretin-enhanced insulin exocytosis alongside the PKA pathway.
5
cAMP-GEFII-dependent insulin secretion requires Rim2, intracellular calcium, and cAMP signaling.

native pancreatic beta-cells and pancreatic islets undergoing incretin-potentiated insulin secretion

the cAMP-GEFII–Rim2 pathway and its PKA-independent, cAMP- and intracellular calcium-dependent contribution to incretin-potentiated insulin secretion

Publication Details
Publication Date
2001-12-01
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Yasushige Kashima
Takashi Miki
Tadao Shibasaki
Nobuaki Ozaki
Masaru Miyazaki
Hideki Yano
Susumu Seino
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%